AZN - AstraZeneca • Dividends
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
See below the complete and updated table with all dividends paid and declared history, etc
DY 2%
DY 2%
1/2
The latest dividend from AZN was $1.073 per share (ex-dividend 8/7/2026). The dividend yield over the last 12 months is 2%. Over the last 12 months there were 2 distributions, totalling $3.222 per share.